2019 novel coronavirus (SARS-CoV-2) is a life-threatening infectious disease caused by SARS-CoV-2. Currently, no effective drug exists to treat SARS-CoV-2 infection. It has led to the empiric use of broad-spectrum antiviral agents in affected patients in several countries. Creative Biolabs has established excellent platforms for drug development. We provide a variety of antiviral agent development services to meet the diverse needs of our customers. Neuraminidase Inhibitors https://sars-cov-2.creative-biolabs.com/neuraminidase-inhibitors-nais-for-the-treatment-of-sars-cov2.htm